8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne
Clinical trial NCT02524665 · COMPLETED
Trial details
- NCT number
- NCT02524665
- Sponsor
- Stiefel, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2009-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.